Selective interactions of transforming and normal abl proteins with ATP, tyrosine-copolymer substrates, and

M Anafi1, A Gazit, C Gilon

  • 1Lautenberg Center for Immunology, Hebrew University Hadassah Medical School, Jerusalem, Israel.

Insights

Transforming abl proteins exhibit higher affinity for ATP and substrates than normal abl. Tyrphostin blockers can distinguish between normal and transforming abl proteins, suggesting targeted leukemia therapies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Normal c-Abl protein (p140c-abl) and transforming abl proteins (p160gag-abl, p185bcr-abl, p210bcr-abl) share catalytic sites but differ in N-terminal domains.
  • Previous research indicated transforming abl proteins have higher tyrosine kinase activity than normal abl proto-oncogene product.

Purpose of the Study:

  • To investigate the substrate affinities of transforming abl proteins compared to the normal abl protein.
  • To determine if protein tyrosine kinase blockers can differentiate between normal and transforming abl proteins.

Main Methods:

  • Assessed the binding affinity of p210bcr-abl and p160gag-abl to ATP and synthetic tyrosine-containing substrates.
  • Tested the ability of tyrphostin family protein tyrosine kinase blockers to discriminate between normal abl and transforming abl proteins from human and mouse sources.

Main Results:

  • p210bcr-abl and p160gag-abl demonstrated higher affinity for ATP and substrates than p140c-abl.
  • Tyrphostins successfully discriminated between normal and transforming abl proteins of both human and mouse origin.

Conclusions:

  • Higher affinities of transforming abl proteins for signal transducers may contribute to their oncogenic potential.
  • This study is the first to show oncogene products differ from homologous proto-oncogene products in substrate specificity.
  • The selectivity of tyrphostins suggests potential for developing specific abl kinase inhibitors for abl-associated leukemias.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Membrane Asymmetry Regulating Transporters01:19

Membrane Asymmetry Regulating Transporters

Enzymes like flippase, floppase, and scramblase transfer phospholipids from one layer to another in the membrane, thereby affecting membrane asymmetry.
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...